• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对血管生成素-2的RNA适配体的计算筛选及实验评估

Computational selection of RNA aptamer against angiopoietin-2 and experimental evaluation.

作者信息

Hu Wen-Pin, Kumar Jangam Vikram, Huang Chun-Jen, Chen Wen-Yih

机构信息

Department of Biomedical Informatics, Asia University, Taichung City 41354, Taiwan ; Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung City 40402, Taiwan.

Department of Biomedical Informatics, Asia University, Taichung City 41354, Taiwan.

出版信息

Biomed Res Int. 2015;2015:658712. doi: 10.1155/2015/658712. Epub 2015 Mar 19.

DOI:10.1155/2015/658712
PMID:25866800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4383501/
Abstract

Angiogenesis plays a decisive role in the growth and spread of cancer and angiopoietin-2 (Ang2) is in the spotlight of studies for its unique role in modulating angiogenesis. The aim of this study was to introduce a computational simulation approach to screen aptamers with high binding ability for Ang2. We carried out computational simulations of aptamer-protein interactions by using ZDOCK and ZRANK functions in Discovery Studio 3.5 starting from the available information of aptamers generated through the systematic evolution of ligands by exponential enrichment (SELEX) in the literature. From the best of three aptamers on the basis of ZRANK scores, 189 sequences with two-point mutations were created and simulated with Ang2. Then, we used a surface plasmon resonance (SPR) biosensor to test 3 mutant sequences of high ZRANK scores along with a high and a low affinity binding sequence as reported in the literature. We found a selected RNA aptamer has a higher binding affinity and SPR response than a reported sequence with the highest affinity. This is the first study of in silico selection of aptamers against Ang2 by using the ZRANK scoring function, which should help to increase the efficiency of selecting aptamers with high target-binding ability.

摘要

血管生成在癌症的生长和扩散中起决定性作用,血管生成素-2(Ang2)因其在调节血管生成中的独特作用而成为研究的焦点。本研究的目的是引入一种计算模拟方法来筛选对Ang2具有高结合能力的适体。我们利用Discovery Studio 3.5中的ZDOCK和ZRANK功能,从文献中通过指数富集的配体系统进化(SELEX)产生的适体的可用信息开始,对适体-蛋白质相互作用进行了计算模拟。根据ZRANK分数从三个最佳适体中,创建了189个具有两点突变的序列,并与Ang2进行模拟。然后,我们使用表面等离子体共振(SPR)生物传感器测试了3个具有高ZRANK分数的突变序列以及文献中报道的一个高亲和力和一个低亲和力结合序列。我们发现一个选定的RNA适体比文献中报道的具有最高亲和力的序列具有更高的结合亲和力和SPR响应。这是首次利用ZRANK评分函数对针对Ang2的适体进行计算机模拟筛选的研究,这将有助于提高筛选具有高靶标结合能力适体的效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/4383501/77c33a332a3d/BMRI2015-658712.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/4383501/49a83547564a/BMRI2015-658712.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/4383501/cbc6f69e3fed/BMRI2015-658712.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/4383501/517a4305eee4/BMRI2015-658712.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/4383501/77c33a332a3d/BMRI2015-658712.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/4383501/49a83547564a/BMRI2015-658712.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/4383501/cbc6f69e3fed/BMRI2015-658712.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/4383501/517a4305eee4/BMRI2015-658712.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/4383501/77c33a332a3d/BMRI2015-658712.004.jpg

相似文献

1
Computational selection of RNA aptamer against angiopoietin-2 and experimental evaluation.针对血管生成素-2的RNA适配体的计算筛选及实验评估
Biomed Res Int. 2015;2015:658712. doi: 10.1155/2015/658712. Epub 2015 Mar 19.
2
More DNA-Aptamers for Small Drugs: A Capture-SELEX Coupled with Surface Plasmon Resonance and High-Throughput Sequencing.更多用于小分子药物的DNA适配体:结合表面等离子体共振和高通量测序的捕获-SELEX技术
ACS Comb Sci. 2015 May 11;17(5):326-33. doi: 10.1021/acscombsci.5b00023. Epub 2015 Apr 28.
3
Searching the Sequence Space for Potent Aptamers Using SELEX in Silico.利用计算机筛选法在序列空间中寻找强效适配体
J Chem Theory Comput. 2015 Dec 8;11(12):5939-46. doi: 10.1021/acs.jctc.5b00707. Epub 2015 Nov 5.
4
Selection of thrombin-binding aptamers by using computational approach for aptasensor application.通过使用计算方法筛选与凝血酶结合的适体用于适体传感器的应用。
Biosens Bioelectron. 2011 Jul 15;26(11):4411-6. doi: 10.1016/j.bios.2011.04.053. Epub 2011 May 6.
5
Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing.使用遗传算法对前列腺特异性抗原的 DNA 适体进行选择及其在传感中的应用。
Biosens Bioelectron. 2010 Dec 15;26(4):1386-91. doi: 10.1016/j.bios.2010.07.057. Epub 2010 Jul 21.
6
A simple method for eliminating fixed-region interference of aptamer binding during SELEX.一种在指数富集的配体系统进化(SELEX)过程中消除适体结合固定区域干扰的简单方法。
Biotechnol Bioeng. 2014 Nov;111(11):2265-79. doi: 10.1002/bit.25294. Epub 2014 Jul 14.
7
Selection of a high-affinity and in vivo bioactive ssDNA aptamer against angiotensin II peptide.针对血管紧张素II肽筛选高亲和力且具有体内生物活性的单链DNA适配体。
Peptides. 2016 Aug;82:101-108. doi: 10.1016/j.peptides.2016.06.004. Epub 2016 Jun 11.
8
Selection of DNA aptamers with affinity for pro-gastrin-releasing peptide (proGRP), a tumor marker for small cell lung cancer.针对胃泌素释放肽前体(proGRP),一种小细胞肺癌的肿瘤标志物,进行具有亲和力的 DNA 适体的选择。
Appl Biochem Biotechnol. 2013 Jan;169(1):250-5. doi: 10.1007/s12010-012-9956-5. Epub 2012 Nov 21.
9
Aptamer selection by direct microfluidic recovery and surface plasmon resonance evaluation.通过直接微流控回收和表面等离子体共振评估进行适配体筛选。
Biosens Bioelectron. 2016 Jun 15;80:418-425. doi: 10.1016/j.bios.2016.02.003. Epub 2016 Feb 3.
10
The screening of RNA aptamers specific for carbonic anhydrase I using the Systematic Evolution of Ligands by an Exponential Enrichment Method (SELEX).使用指数富集配体系统进化法(SELEX)筛选针对碳酸酐酶I的RNA适配体。
Nucleosides Nucleotides Nucleic Acids. 2014;33(11):697-708. doi: 10.1080/15257770.2014.931587.

引用本文的文献

1
Aptamers as Potential Inhibitors of Ethylene Biosynthesis: Identification and In Silico Selection.适体作为乙烯生物合成的潜在抑制剂:鉴定与计算机筛选
Int J Mol Sci. 2025 Aug 22;26(17):8146. doi: 10.3390/ijms26178146.
2
Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy.通过EphA2靶向胶质母细胞瘤干细胞:用于精准治疗的RNA适配体A40s的结构见解
J Chem Inf Model. 2025 Jun 9;65(11):5635-5648. doi: 10.1021/acs.jcim.5c00295. Epub 2025 May 23.
3
Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1.

本文引用的文献

1
Automated 3D structure composition for large RNAs.自动化 3D 大型 RNA 结构构建。
Nucleic Acids Res. 2012 Aug;40(14):e112. doi: 10.1093/nar/gks339. Epub 2012 Apr 26.
2
Structural models of protein-DNA complexes based on interface prediction and docking.基于界面预测和对接的蛋白质-DNA 复合物结构模型。
Curr Protein Pept Sci. 2011 Sep;12(6):531-9. doi: 10.2174/138920311796957694.
3
Selection of thrombin-binding aptamers by using computational approach for aptasensor application.通过使用计算方法筛选与凝血酶结合的适体用于适体传感器的应用。
例50:T适体通过靶向gremlin-1削弱乳腺癌中的肿瘤-基质相互作用。
Cell Death Discov. 2025 Mar 11;11(1):94. doi: 10.1038/s41420-025-02363-6.
4
Posterior eye delivery of angiogenesis-inhibiting RNA nanoparticles via subconjunctival injection.经结膜下注射递送至眼后段的血管生成抑制 RNA 纳米颗粒。
Int J Pharm. 2024 May 25;657:124151. doi: 10.1016/j.ijpharm.2024.124151. Epub 2024 Apr 23.
5
The Application of Aptamer and Research Progress in Liver Disease.适体在肝脏疾病中的应用及研究进展。
Mol Biotechnol. 2024 May;66(5):1000-1018. doi: 10.1007/s12033-023-01030-4. Epub 2024 Feb 2.
6
Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?人工智能能否彻底改变用于基因治疗和mRNA疫苗的纳米载体的研发?
Nano Today. 2022 Dec;47. doi: 10.1016/j.nantod.2022.101665. Epub 2022 Nov 7.
7
Design and Prediction of Aptamers Assisted by In Silico Methods.计算机辅助方法辅助的适配体设计与预测
Biomedicines. 2023 Jan 26;11(2):356. doi: 10.3390/biomedicines11020356.
8
Inspirations of Biomimetic Affinity Ligands: A Review.仿生亲和配体的启示:综述
ACS Omega. 2022 Sep 9;7(37):32897-32907. doi: 10.1021/acsomega.2c03530. eCollection 2022 Sep 20.
9
In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein.基于计算机的 SARS-CoV-2 刺突蛋白适配体靶标选择。
Int J Mol Sci. 2022 May 22;23(10):5810. doi: 10.3390/ijms23105810.
10
design of quadruplex aptamers against the spike protein of SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的四重适体设计
Inform Med Unlocked. 2021;26:100757. doi: 10.1016/j.imu.2021.100757. Epub 2021 Oct 14.
Biosens Bioelectron. 2011 Jul 15;26(11):4411-6. doi: 10.1016/j.bios.2011.04.053. Epub 2011 May 6.
4
Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.靶向 ANG2/TIE2 轴通过抑制血管生成和使促血管生成的髓样细胞的反弹失活来抑制肿瘤生长和转移。
Cancer Cell. 2011 Apr 12;19(4):512-26. doi: 10.1016/j.ccr.2011.02.005.
5
Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing.使用遗传算法对前列腺特异性抗原的 DNA 适体进行选择及其在传感中的应用。
Biosens Bioelectron. 2010 Dec 15;26(4):1386-91. doi: 10.1016/j.bios.2010.07.057. Epub 2010 Jul 21.
6
Targeting the ANGPT-TIE2 pathway in malignancy.针对恶性肿瘤中的 ANGPT-TIE2 通路。
Nat Rev Cancer. 2010 Aug;10(8):575-85. doi: 10.1038/nrc2894.
7
Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth.血管生成素-2 和 VEGF 抑制剂对肿瘤血管生成和生长的协同作用。
Cancer Res. 2010 Mar 15;70(6):2213-23. doi: 10.1158/0008-5472.CAN-09-1977. Epub 2010 Mar 2.
8
A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models.一种人源化抗 ANG2 单克隆抗体与 VEGF 抑制剂和化疗药物联合在临床前模型中具有广泛的抗肿瘤活性。
Mol Cancer Ther. 2010 Jan;9(1):145-56. doi: 10.1158/1535-7163.MCT-09-0554. Epub 2010 Jan 6.
9
In silico selection of RNA aptamers.RNA适配体的计算机模拟筛选
Nucleic Acids Res. 2009 Jul;37(12):e87. doi: 10.1093/nar/gkp408. Epub 2009 May 21.
10
CENTROIDFOLD: a web server for RNA secondary structure prediction.CENTROIDFOLD:一个用于RNA二级结构预测的网络服务器。
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W277-80. doi: 10.1093/nar/gkp367. Epub 2009 May 12.